Herman Nilsson‐Ehle

Author

Herman Nilsson‐Ehle

Also Known As

Bo Norberg, H Nilsson-Ehle, H. Nilsson-Ehle, H. Nilsson‐Ehle, HERMAN NILSSON‐EHLE, Herman Nilsson-Ehle, Herman Nilsson‐Ehle, Nilsson-Ehle, H., Nilsson-Ehle, Herman

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Sahlgrenska University Hospital University of Gothenburg Lund University Uppsala University Hospital Aarhus University Hospital

About

Herman Nilsson‐Ehle is an author at Sahlgrenska University Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.3K
2	Health Sciences	9	9	847
3	Public Health	2	2	129
4	Cell Biology	2	2	34
5	Cellular Therapies	1	1	265

Herman Nilsson‐Ehle

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group Christian H. Geisler, Arne Kolstad, Anna Laurell, Blood	2008	619
Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin, Blood	1998	306
Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur Christian H. Geisler, Arne Kolstad, Anna Laurell, British Journal of Haematology Cell TherapyImmunologyPathologyCell Replacement TherapyImmunotherapy	2012	265
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (<scp>MCL</scp>2): prolonged remissions without survival plateau Christian Winther Eskelund, Arne Kolstad, Mats Jerkeman, British Journal of Haematology ImmunologyPathologyHematological MalignancyOncologyHematology	2016	207
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT) Christian H. Geisler, Arne Kolstad, Anna Laurell, Blood	2009	184
Blood haemoglobin declines in the elderly: implications for reference intervals fromage 70 to 88 Herman Nilsson‐Ehle, R Jagenburg, Sten Landahl, European Journal Of Haematology	2000	161
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial Judith Trotman, Sally F. Barrington, David Belada, The Lancet Oncology Lymphoid NeoplasiaEnd-of-induction Pet ResponseMedicinePrognostic ValueFollicular Lymphoma	2018	152
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study Anna Abrahamsson, Alexandra Albertsson‐Lindblad, Peter de Nully Brown, Blood	2014	133
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study Catharina Lewerin, Michael Matousek, Gunilla Steen, American Journal of Clinical Nutrition Plasma HomocysteineAlzheimer's DiseaseAgingCognitive PerformanceGeriatrics	2005	132
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study Henna Riikka Junlén, Stefan Peterson, Eva Kimby, Leukemia Lymphoid NeoplasiaElderly WomenFollicular LymphomaGynecologyRituximab Era	2014	130

Page 1